# 8.5.11 Colorado tick fever and other arthropod- bo

# 8.5.11 Colorado tick fever and other arthropod- borne reoviruses 819

8.5.11  Colorado tick fever and other arthropod-borne reoviruses
819
which are presumably vectors. It was isolated from a child with 
meningitis who recovered, and from another with fatal encephal-
itis. Mokola virus also caused mild disease in a rabies-​vaccinated 
laboratory worker.
	•	Duvenhage virus (species 4) has been identified in three people, 
all of whom had had skin lesions inflicted by bats and had 
developed a fatal illness with clinical features identical to rabies 
encephalitis.
European bat lyssaviruses
Infected insectivorous bats have been found in Europe since 1954. 
The European bat lyssavirus (EBLV) group comprises species 5 (also 
known as EBLV 1) and species 6 (EBLV 2), which have subgroups a 
and b. EBLV type 1a is found across Northern and Eastern Europe 
from the Netherlands to Russia; EBLV type 1b in the Netherlands, 
France, and Spain; EBLV type 2a in the Netherlands and the United 
Kingdom; EBLV type 2b rarely in Switzerland and Scandinavia. 
Five unvaccinated people with bat bites died of encephalitis indis-
tinguishable from rabies: two infected in Russia, one each in the 
Ukraine, Scotland, and Finland.
Australian bat lyssavirus
Australian bat lyssavirus (species 7) has been found in fruit bats 
(genus Pteropus) (Fig. 8.5.10.16) and insectivorous bats in Eastern 
Australia since 1996. It caused a fatal rabies-​like encephalitis in three 
people who had handled bats.
FURTHER READING
Banyard AC, et al. (2011). Bats and lyssaviruses. Adv Virus Res, 79, 
239–​89.
Gautret P, et al. (2014). Rabies in nonhuman primates and potential 
for transmission to humans: a literature review and examination of 
selected French national data. PLoS Negl Trop Dis, 8, e2863.
Gnanadurai CW, et al. (2015). Novel approaches to the prevention and 
treatment of rabies. Int J Virol Stud Res, 3, 8–​16.
Helmick CG, Tauxe RV, Vernon AA (1987). Is there a risk to contacts 
of patients with rabies? Rev Infect Dis, 9, 511–​18.
Kaplan C, Turner GS, Warrell DA (eds) (1986). Rabies:  the facts,  
revised edition. Oxford University Press, Oxford.
Manning SE, et al. (2008). Human rabies prevention—​United States, 
2008: recommendations of the Advisory Committee on Immunization 
Practices. MMWR Recomm Rep, 57(RR-​3), 1–​28.
Nel LH, Markotter W (2007). Lyssaviruses. Crit Rev Microbiol, 33, 
301–​24.
Schnell MJ, et al. (2010). The cell biology of rabies virus: using stealth 
to reach the brain. Nat Rev Microbiol, 8, 51–​61.
Warrell DA, et al. (1976). Pathophysiologic studies in human rabies. 
Am J Med, 60, 180–​90.
Warrell MJ (2012). Current rabies vaccines and prophylaxis sched-
ules: preventing rabies before and after exposure. Travel Med Infect 
Dis, 10, 1–​15.
Warrell MJ, Warrell DA, Tarantola A (2017). The imperative of palli-
ation in the management of rabies encephalomyelitis. Trop Med 
Infect Dis, 2, 52.
World Health Organization (2018). Expert consultation on rabies. 
Third report. World Health Organ Tech Rep Ser, 1012.
Zeiler FA, Jackson AC (2016). Critical appraisal of the milwaukee 
protocol for rabies: This failed approach should be abandoned. 
Can J Neurol Sci, 43, 44–51.
8.5.11  Colorado tick fever and other 
arthropod-​borne reoviruses
Mary J. Warrell and David A. Warrell
ESSENTIALS
Human pathogens are found in six genera of Reoviridae:  
Reovirus, Rotavirus, Orthoreovirus, and three arthropod-​borne 
genera—​Coltivirus (Colorado tick fever, Salmon River virus, and 
Eyach viruses), Orbivirus (Kemerovo group, Changuinola, Orungo, 
and Lebombo) and Seadornavirus (Banna virus).
Colorado tick fever—​common in parts of north-​western North 
America; acquired from hard tick (ixodid) bites, most often by 
hikers and campers, presenting 3–​6 days later with sudden fever, 
rigors, generalized aches, myalgia, headache and backache, rashes 
(12%), and gastrointestinal symptoms (20%). Diagnosis is con-
firmed by detection of viral antigen in erythrocytes or serum, or 
Fig. 8.5.10.16  Pteropid fruit bats (flying foxes) (Pteropis) roosting, the 
natural reservoir of Nipah, Hendra, and Menangle paramyxoviruses, and 
of Australian bat lyssavirus.
Copyright David A. Warrell.


820
section 8  Infectious diseases
by serodiagnosis. Management is symptomatic. Illness usually 
resolves in 10–​14  days, but convalescence may be prolonged. 
Prevention is by avoiding, repelling, or rapidly removing ticks; no 
vaccines are available.
Coltiviruses
Colorado tick fever
The virus responsible for Colorado tick fever or ‘mountain fever’ 
is an 80-​nm double-​shelled particle covered with capsomeres. 
The icosahedral core contains 12 segments of double-​stranded 
negative-​sense RNA. The virus can infect human erythro-
cytes and this may also occur with the other coltiviruses and 
orbiviruses.
Colorado tick fever is a zoonosis involving hard (ixodid) ticks 
(principally Dermacentor andersoni, but also D. occidentalis, 
D. parumapertus, D. albipictus, and others) and wild mammals, 
including porcupines, deer, coyotes, squirrels, chipmunks, deer 
mice, and other rodents. Ticks pass Colorado tick fever virus 
transstadially and transovarially.
Epidemiology
Colorado tick fever is acquired from tick bites in western and 
north-​western parts of the United States of America (including 
California) and Canada (British Columbia and Alberta). Very 
rarely, it has been caused by an infected blood transfusion. In the 
United States of America over 10 years up to 2012, 75 cases were 
reported mostly in Wyoming and other western states. Although 
underreporting is suspected, the incidence seems to have been 
declining. Hikers and campers are at special risk in rodent-​ and 
tick-​infested terrain. The prevalence of antibody to Colorado 
tick fever among shepherds was 32%. The highest incidence is 
from May to July when ticks are most active. Infection usually 
confers lasting immunity.
Clinical features
In adults, the infection is nearly always mild, but in children it is 
occasionally severe but rarely fatal. Three to six days after the tick 
bite (extreme range 1–​19 days) there is a sudden fever for about 
3 days, with rigors, generalized aches, myalgia, headache, and back-
ache. In one-​half of the patients there is a biphasic fever. Rashes 
then appear in up to 12% of patients, usually a transient peripheral 
maculopapular rash or petechiae on flexor surfaces of arms but can 
be widespread and it may be hyperaesthetic. Gastrointestinal symp-
toms occur in 20% of patients. Laboratory findings include leuko-
penia with relative lymphocytosis, occasional thrombocytopenia, 
and mild lymphocyte pleocytosis.
The illness usually resolves in about 10–​14  days, but conva-
lescence may be prolonged. Severe manifestations include en-
cephalitis, meningitis, or drowsiness, sometimes associated with 
gastrointestinal symptoms, spontaneous bleeding, thrombocyto-
penia, and disseminated intravascular coagulation. Fatalities 
are rarely reported in children and one immunosuppressed 
adult. Late, possibly immunological effects include myocarditis, 
pericarditis, pleurisy, arthritis, and epididymitis. Colorado tick 
fever infection may precipitate abortion or transplacental infec-
tion, but the teratogenic effects reported in mice have not been 
observed in humans.
Diagnosis
Viral antigen may be detected in erythrocytes by immunofluor-
escence 1–​120 days after the start of symptoms. Erythrocyte pre-
cursors are infected in the marrow, but their survival is apparently 
not affected. Virus can be isolated from the blood and, if there is cen-
tral nervous system involvement, the cerebrospinal fluid. Colorado 
tick fever virus produces a cytopathic effect on several cell lines, but 
intracerebral injection of ground blood clot or preferably washed 
erythrocytes into suckling mice is more sensitive for diagnostic iso-
lation. Antigen can be detected in serum during acute infections, 
especially the first 2 weeks after onset, by polymerase chain reaction 
(RT-​PCR), but enzyme-​linked immunosorbent assay techniques 
have been less sensitive. Neutralizing antibody and specific IgM en-
zyme immunoassays become positive after 14–​21 days and the IgM 
disappears after 45 days.
Differential diagnosis
Many other tick-​borne acute febrile illnesses, some with rashes 
and nervous system involvement, can be acquired in the area en-
demic for Colorado tick fever. These include Rocky Mountain 
spotted fever, tularaemia, Lyme disease, and relapsing fever. Tick 
paralysis caused by D. andersoni and other ixodid ticks presents 
as a poliomyelitis-​like, ascending, flaccid paralysis that is unlikely 
to be mistaken for the meningitic or encephalitic syndromes of 
Colorado tick fever.
Treatment
The symptomatic treatment of fever and pain should exclude sali-
cylates in case of thrombocytopenia. Tribavirin (ribavirin) inhibits 
the replication of Colorado tick fever virus experimentally, but its 
use in humans has not been reported. Immunity is long-​lasting. 
Convalescent patients should not donate blood for 6 months after 
their illness.
Salmon River virus
This virus is closely related to Colorado tick fever virus. It was iso-
lated from a patient with similar symptoms in Idaho.
Eyach
This European coltivirus has been found in ticks in Germany and 
France and is likely to be an adapted variant Colorado tick fever 
virus introduced from America. There is serological evidence of 
human infection in Czechoslovakia causing meningoencephalitis or 
neuropathies.
Orbiviruses
Although the respective antibodies to the tick-​borne Great Island 
virus and insect-​borne Corripata orbiviruses have been found in 
humans, there is no evidence of the diseases’ pathogenicity.